| Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy J Wang, J Sun, LN Liu, DB Flies, X Nie, M Toki, J Zhang, C Song, M Zarr, ... Nature medicine 25 (4), 656-666, 2019 | 596 | 2019 |
| Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non–small cell lung cancer using spatially resolved and multiparametric single-cell analysis I Datar, MF Sanmamed, J Wang, BS Henick, J Choi, T Badri, W Dong, ... Clinical Cancer Research 25 (15), 4663-4673, 2019 | 299 | 2019 |
| A quantitative comparison of antibodies to programmed cell death 1 ligand 1 P Gaule, JW Smithy, M Toki, J Rehman, F Patell-Socha, D Cougot, ... JAMA oncology 3 (2), 256-259, 2017 | 206 | 2017 |
| Spatially resolved and quantitative analysis of VISTA/PD-1H as a novel immunotherapy target in human non–small cell lung cancer F Villarroel-Espindola, X Yu, I Datar, N Mani, M Sanmamed, V Velcheti, ... Clinical Cancer Research 24 (7), 1562-1573, 2018 | 196 | 2018 |
| High-plex predictive marker discovery for melanoma immunotherapy–treated patients using digital spatial profiling MI Toki, CR Merritt, PF Wong, JW Smithy, HM Kluger, KN Syrigos, GT Ong, ... Clinical Cancer Research 25 (18), 5503-5512, 2019 | 160 | 2019 |
| Multiplex quantitative analysis of tumor-infiltrating lymphocytes and immunotherapy outcome in metastatic melanoma PF Wong, W Wei, JW Smithy, B Acs, MI Toki, KRM Blenman, D Zelterman, ... Clinical Cancer Research 25 (8), 2442-2449, 2019 | 139 | 2019 |
| Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study B Acs, V Pelekanou, Y Bai, S Martinez-Morilla, M Toki, SCY Leung, ... Laboratory Investigation 99 (1), 107-117, 2019 | 129 | 2019 |
| B7-H3 expression in NSCLC and its association with B7-H4, PD-L1 and tumor-infiltrating lymphocytes M Altan, V Pelekanou, KA Schalper, M Toki, P Gaule, K Syrigos, ... Clinical Cancer Research 23 (17), 5202-5209, 2017 | 123 | 2017 |
| Immune checkpoint inhibitor–associated pericarditis M Altan, MI Toki, SN Gettinger, DE Carvajal-Hausdorf, J Zugazagoitia, ... Journal of Thoracic Oncology 14 (6), 1102-1108, 2019 | 99 | 2019 |
| Immune marker profiling and programmed death ligand 1 expression across NSCLC mutations MI Toki, N Mani, JW Smithy, Y Liu, M Altan, B Wasserman, R Tuktamyshov, ... Journal of Thoracic Oncology 13 (12), 1884-1896, 2018 | 98 | 2018 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 91 | 2021 |
| Oncogenic EGFR represses the TET1 DNA demethylase to induce silencing of tumor suppressors in cancer cells M Forloni, R Gupta, A Nagarajan, LS Sun, Y Dong, V Pirazzoli, M Toki, ... Cell reports 16 (2), 457-471, 2016 | 62 | 2016 |
| Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium … LF Reyes, S Murthy, E Garcia-Gallo, M Irvine, L Merson, I Martin-Loeches, ... ERJ open research 8 (1), 2022 | 60 | 2022 |
| Quantitative assessment of CMTM6 in the tumor microenvironment and association with response to PD-1 pathway blockade in advanced-stage non–small cell lung cancer J Zugazagoitia, Y Liu, M Toki, J McGuire, FS Ahmed, BS Henick, R Gupta, ... Journal of Thoracic Oncology 14 (12), 2084-2096, 2019 | 60 | 2019 |
| Proof of the quantitative potential of immunofluorescence by mass spectrometry MI Toki, F Cecchi, T Hembrough, KN Syrigos, DL Rimm Laboratory Investigation 97 (3), 329-334, 2017 | 50 | 2017 |
| Biomarker discovery in patients with immunotherapy-treated melanoma with imaging mass cytometry S Martinez-Morilla, F Villarroel-Espindola, PF Wong, MI Toki, TN Aung, ... Clinical Cancer Research 27 (7), 1987-1996, 2021 | 46 | 2021 |
| Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer M Altan, KM Kidwell, V Pelekanou, DE Carvajal-Hausdorf, KA Schalper, ... NPJ Breast Cancer 4 (1), 40, 2018 | 46 | 2018 |
| Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer FJ de Miguel, C Gentile, WW Feng, SJ Silva, A Sankar, F Exposito, ... Cancer Cell 41 (8), 1516-1534. e9, 2023 | 45 | 2023 |
| ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19 M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ... Scientific data 9 (1), 454, 2022 | 45 | 2022 |
| The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 40 | 2021 |
